About us
The identification of promising new hits and their optimization into high-quality lead series is an essential step in the early stages of the modern drug discovery process. We established the Molecules Initiative for Neglected Diseases Consortium (MINDI) to discover novel drug candidates for clinical development for malaria, Chagas disease and leishmaniasis.
Learn more
Research
The approach of MINDI Consortium is to use hits from both MMV and DNDi screening campaigns as starting points for lead optimization projects.
Learn moreArticles and papers
2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling
Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Partners
Unicamp
Rua Josué de Castro, s/n
Cidade Universitária Campinas
CEP: 13083-970 – SP
© 2024 - Unicamp